Management of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients using Inhaled Antibiotics...
Management of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients using Inhaled Antibiotics with a Focus on Nebulized Liposomal Amikacin
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Pseudomonas aeruginosa (PsA) is a highly prevalent bacterial organism recovered from the lungs of cystic fibrosis (CF) patients and chronic PsA infection is linked to progressive pulmonary function decline. The eradication and treatment of this organism from CF airways is particularly challenging to CF care providers. Aerosolized antibiotics that t...
Alternative Titles
Full title
Management of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients using Inhaled Antibiotics with a Focus on Nebulized Liposomal Amikacin
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4944396
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4944396
Other Identifiers
ISSN
1746-0913
E-ISSN
1746-0921
DOI
10.2217/fmb.15.117
